Literature DB >> 15330000

Test review-Comprehensive Trail Making Test (CTMT).

James A Moses1.   

Abstract

Mesh:

Year:  2004        PMID: 15330000     DOI: 10.1016/j.acn.2004.02.004

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


× No keyword cloud information.
  14 in total

Review 1.  Contemporary considerations in cranial-base surgery.

Authors:  Charles E Moore; G Aaron Rogers
Journal:  Medscape J Med       Date:  2008-12-03

2.  The Relationship between Older Drivers' Performance on the Driving Observation Schedule (eDOS) and Cognitive Performance.

Authors:  Sjaan Koppel; Judith Charlton; Jim Langford; Zafiroula Vlahodimitrakou; Marilyn Di Stefano; Wendy Macdonald; Barbara Mazer; Isabelle Gelinas; Brenda Vrkljan; Shawn Marshall
Journal:  Ann Adv Automot Med       Date:  2013

3.  Early adolescent executive functioning, intrauterine exposures and own drug use.

Authors:  Ruth Rose-Jacobs; Shayna Soenksen; Danielle P Appugliese; Howard J Cabral; Mark A Richardson; Marjorie Beeghly; Timothy C Heeren; Deborah A Frank
Journal:  Neurotoxicol Teratol       Date:  2011-03-01       Impact factor: 3.763

4.  Inflammation, Attention, and Processing Speed in Patients With Breast Cancer Before and After Chemotherapy.

Authors:  Elizabeth K Belcher; Eva Culakova; Nikesha J Gilmore; Sara J Hardy; Amber S Kleckner; Ian R Kleckner; Lianlian Lei; Charles Heckler; Michael B Sohn; Bryan D Thompson; Louis T Lotta; Zachary A Werner; Jodi Geer; Judith O Hopkins; Steven W Corso; David Q Rich; Edwin van Wijngaarden; Michelle C Janelsins
Journal:  J Natl Cancer Inst       Date:  2022-05-09       Impact factor: 11.816

5.  Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.

Authors:  Shelli R Kesler; Douglas W Blayney
Journal:  JAMA Oncol       Date:  2016-02       Impact factor: 31.777

Review 6.  Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence.

Authors:  Edward Tobinick
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749

7.  Cortical Brain Age from Pre-treatment to Post-chemotherapy in Patients with Breast Cancer.

Authors:  Ashley Henneghan; Vikram Rao; Rebecca A Harrison; Meghan Karuturi; Douglas W Blayney; Oxana Palesh; Shelli R Kesler
Journal:  Neurotox Res       Date:  2020-01-04       Impact factor: 3.911

8.  The negative impact of chronic tobacco smoking on adult neuropsychological function: a cross-sectional study.

Authors:  Mohammed Sh Nadar; Abdullah M Hasan; Mohammed Alsaleh
Journal:  BMC Public Health       Date:  2021-06-30       Impact factor: 3.295

9.  Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer's disease.

Authors:  Frank M Schmidt; Juergen Kratzsch; Hermann-Josef Gertz; Mandy Tittmann; Ina Jahn; Uta-Carolin Pietsch; Udo X Kaisers; Joachim Thiery; Ulrich Hegerl; Peter Schönknecht
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

10.  Changes in Brain Functional and Effective Connectivity After Treatment for Breast Cancer and Implications for Intervention Targets.

Authors:  Nicholas S Phillips; Vikram Rao; Lorie Kmetz; Ruben Vela; Sarah Medick; Kevin Krull; Shelli R Kesler
Journal:  Brain Connect       Date:  2021-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.